SOX combined with tislelizumab and low-dose radiation therapy for the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase Ib/II clinical trial

Authors

Mo‐Jin Wang (ORCID: https://orcid.org/0000-0002-1592-8798)
Zhumei Luo (ORCID: https://orcid.org/0000-0001-7428-9853)
Ji Chen
Kun Qian (ORCID: https://orcid.org/0000-0003-1157-5400)
Ming Liu (ORCID: https://orcid.org/0000-0002-4693-0073)
Pengfei Zhang (ORCID: https://orcid.org/0000-0002-7090-0325)
Xiaodong Chen (ORCID: https://orcid.org/0000-0001-5717-849X)
Wenke Li (ORCID: https://orcid.org/0000-0002-2172-8709)
Ye Chen (ORCID: https://orcid.org/0009-0007-6024-6562)

Institutions

University of Electronic Science and Technology of China (CN)
Sichuan University (CN)
Third People's Hospital of Chengdu (CN)
Sichuan Cancer Hospital (CN)
The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
Seventh People's Hospital of Shanghai (CN)
State Key Laboratory of Biotherapy
Chongqing Medical University (CN)

Publication Details

Journal: Frontiers in Immunology
Published: 2024-11-13
DOI: https://doi.org/10.3389/fimmu.2024.1431957
Citations: 3
Primary Topic: Gastric Cancer Management and Outcomes
Type: article
Field-Weighted Citation Impact: 1.26

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

SOX combined with tislelizumab and low-dose radiation therapy for the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase Ib/II clinical trial

Mo‐Jin Wang, Zhumei Luo, Ji Chen, Kun Qian et al.

Nov 13, 2024

3 citations

Frontiers in Immunology

Gastric Cancer Management and Outcomes

1.26

article

SOX combined with tislelizumab and low-dose radiation therapy for the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase Ib/II clinical trial

Mo‐Jin Wang, Zhumei Luo, Ji Chen, Kun Qian, Ming Liu, Pengfei Zhang, Xiaodong Chen, Wenke Li, Ye Chen

November 13, 2024article en

3 citations

Abstract

No abstract available for this paper.

Frontiers in ImmunologyVol. 15

University of Electronic Science and Technology of China (CN), Sichuan University (CN), Third People's Hospital of Chengdu (CN), Sichuan Cancer Hospital (CN), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), Seventh People's Hospital of Shanghai (CN), State Key Laboratory of Biotherapy, Chongqing Medical University (CN)

Good health and well-being

Openalex Percentile: Top 18%

Gastric Cancer Management and Outcomes

1.26

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

SOX combined with tislelizumab and low-dose radiation therapy for the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase Ib/II clinical trial — Mo‐Jin Wang, Zhumei Luo, et al. · Frontiers in Immunology (2024) | TGRS Research Map | TGRS